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Background: With the Convulsive Status Guidelines due for renewal, we wondered if a phenytoin dose of ‘20 mg/kg’
would be easier to calculate correctly and therefore safer than the current ‘18 mg/kg’. An educational exercise in dose
calculation was therefore undertaken to assess ease of calculation.
Method: A standard question paper was prepared, comprising five clinical scenarios with children of varying ages and
estimated body weights. Medical students, trainee doctors at registrar and senior house officer level, and consultant
paediatricians were asked to complete the exercise, in private, by one of two medical students (SD, PS). Calculations
were done with and without a calculator, for 18 mg/kg and for 20 mg/kg in randomised order. Speed and errors
(greater than 10%) were determined. The data analysis was performed using SPSS version 18.
Results: All answered all 20 scenarios, giving a total of 300 answers per doctor/student group, and 300 answers per
type of calculation. When comparing the 2 doses, the numbers of errors more than 10% were significantly less in
20 mg/kg dose (0.33%) as compared to the 18 mg/kg dose (9.3%) (p<0.0001). Speed off calculation was significantly
decreased in 20 mg/kg dose when compared with 18 mg/kg dose, with (p<0.001) or without (p<0.0001) the calculator.
Speed was more than halved and errors were much less frequent by using a calculator, for the 18 mg/kg dose but no
difference with or without the calculator for 20 mg/kg dose.
Conclusion: We recommend that the future guidelines should suggest iv Phenytoin at 20 mg/kg rather than 18 mg/kg.
This will make the calculation easier and reduce the risk of significant errors.Background
With the convulsive status epilepticus in children guide-
line due for renewal, we wondered if a Phenytoin dose of
‘20 mg/kg’ would be easier to calculate correctly and
therefore safer than the previously recommended ‘18 mg/
kg’ dose. An educational exercise in dose calculation was
therefore undertaken.
Convulsive status epilepticus (CSE) is defined as a con-
tinuous or recurrent convulsive seizure with loss of con-
sciousness lasting 30 minutes or more, or a cluster of
repeated convulsions during which consciousness is not
regained, lasting 30 minutes or more [1]. CSE in childhood* Correspondence: william.whitehouse@nottingham.ac.uk
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reproduction in any medium, provided the orconstitutes a medical emergency as it is a life threatening
condition with serious risk of neurological squelae [2]. In
addition, the longer the duration of the episode, the more
difficult it is to terminate [3].
Data from epidemiological studies suggest that four to
eight children per 1000 may be expected to experience
an episode of CSE before the age of 15 years [4], and in
children with first seizures, 12% present with CSE as
their first unprovoked seizure [5]. CSE in children has a
mortality of approximately 4% [6].
The 2000 guideline by the ‘Status Epilepticus Working
Party’ for treating and preventing status epilepticus by
treating prolonged convulsive seizures (lasting more that
5 or 10 minutes) in children in the UK, advised infusion
of 18 mg/kg of Phenytoin by slow intravenous (iv) infu-
sion over 20 minutes as a third line treatment if otherLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Prasad et al. BMC Pediatrics 2013, 13:60 Page 2 of 5
http://www.biomedcentral.com/1471-2431/13/60treatments (generally benzodiazepines) had failed to
control the seizure [7]. However, there is little agreement
between hospital protocols when treating CSE in chil-
dren globally, and it is well known that many hospitals
in the UK and in North America use 20 mg/kg dose [8].
The objective of this study was to test medical students,
trainees and consultant doctors as part of an educational
exercise in dose calculation, and see if it is easier and less
prone to error to calculate a dose of 20 mg/kg rather than
18 mg/kg.Methods
A standard question paper was prepared, comprising five
clinical scenarios with children of varying ages and esti-
mated body weights. Medical students, trainee doctors at
registrar and senior house officer (SHO) level, and con-
sultant paediatricians were asked to complete the exercise,
confidentially, anonymously, in private, as an educational
exercise, by one of two medical students (SD, PS).
Calculations were done with and without a calculator,
for 18 mg/kg and for 20 mg/kg in randomised order.
Speed was recorded with a stop watch, and errors were
determined. For our exercise, only calculation errors of
greater than 10% different from the correct dose were
counted as significant errors.
The whole exercise took 5–10 minutes of the student’s
or doctor’s time.
The data analysis was performed using SPSS version
18 (SPSS Inc, Chicago, IL). Continuous variables were
tested for normality using Kolmogrov-Smirnov test and
Wilcoxson signed rank test was used for paired data
when not normally distributed. One way ANOVA with
post hoc analysis using Dunnett C test (unequal vari-
ance) was performed for normally distributed data when
comparing effect of level of seniority on time taken to
calculate. The categorical data was analysed using
Fischer’s exact test and p values below 0.05 were taken
as significant.
This was not experimental research, this was an edu-
cational exercise, so no ethics committee approval was
required and no written consent was obtained,Table 1 Number of dose calculation errors observed







Significant error >10% 2/300 28/300 3/300
Speed of calculation in seconds
(range)
8 (2–36) 18 (2–77) 6 (1–39)
Comparison of number of significant errors in drug calculation of > 10%, when aske
the calculator (top row). Speed of calculation (seconds) expressed as median and ra
20 mg/kg dose with and without the use of a calculator (bottom row).
* p < 0.001 Fischer exact test.
** p < 0.001 Wilcoxson sign ranked test.Results
Data was collected from the 20 scenarios as completed
by 15 consultant paediatricians, 15 registrars, 15 SHOs,
and 15 medical students. All answered all 20 scenarios,
giving a total of 300 answers per doctor/student group,
and 300 answers per type of calculation (Table 1).
The students’ and doctors’ performances were similar,
with respect to the significant error rate (Figure 1). There
was a significant effect of seniority on the time taken to
calculate the dose (Figure 2, Figure 3), F (3,658) = p < 0.05.
There was a significant quadratic trend with the time taken
decreasing with seniority at registrar level and then again
increasing with seniority, F(3, 658) = p = 0.028. Post hoc
analysis shows registrars’ calculations were signifi-
cantly faster than medical students’ (p < 0.001) and
SHO’s (p = 0.006) (Figure 4). There was no significant
order effect.
Error rate > 10%
When comparing the 2 doses, the numbers of errors
more than 10% were significantly less for the 20 mg/kg
dose (0.33%) compared to the 18 mg/kg dose (9.3%)
(p < 0.0001, Fischer exact test) when not using the calcula-
tor. The odds ratio for making a significant error is 30.77
with increased risk for the 18 mg/kg calculation. There
was no significant difference in the significant error rate
when using a calculator.
When using the 18 mg/kg dose, using a calculator sig-
nificantly decreased the significant error rate from 9.3%
to 0.66% (p < 0.001). The odds ratio of making an error
while calculating the 18 mg/kg dose without a calculator
was 15.38 as compared to when using a calculator.
For the 20 mg/kg doses, there was no difference in sig-
nificant error rate with or without a calculator (1% vs.
0.3%), in fact, with the 20 mg/kg dose, the significant
error rate was less without a calculator.
Speed of calculation
When comparing the 2 doses, the time taken to per-
form the calculations was significantly decreased using
the 20 mg/kg dose as compared to 18 mg/kg dose with











1/300 NS * * NS
4 (1–44) ** ** ** NS
d to calculate 18 mg/kg dose and 20 mg/kg dose with and without the use of
nge for making the calculations when asked to calculate 18 mg/kg dose and
Figure 1 Significant errors by type of calculation and category of doctor or medical student.
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18 seconds respectively, T = 39, p < 0.0001, r = 0.79) a
calculator.
For the 18 mg/kg doses, speed of calculation was bet-
ter than halved by using a calculator (8.0 vs. 18.0 sec-
onds) which is statistically significant (T = 39, p < 0.001,
r = 0.75), however for the 20 mg/kg dose there was no
significant difference in time taken with (median 6 sec-
onds) or without (median 4 seconds) the calculator. In
fact the speed was quicker without the calculator for the
20 mg/kg dose.
Discussion
Medication errors are considered to be the commonest
type of medical error, [9-11] and recent reviews have
established that paediatric patients are at particularly
high risk compared to adults [12,13]. It is estimated that
the true incidence of paediatric dosing errors could beFigure 2 Mean time taken to perform the calculation and category ofapproximately 500,000 per year in England. There is,
therefore, an urgent need to minimise such errors [14].
Published literature confirms that some healthcare pro-
fessionals have difficulty calculating correct doses [15-17].
Phenytoin is one of the most effective drugs for
treating acute convulsive seizures, whether primarily or
secondarily generalised, and status epilepticus. The main
advantage of Phenytoin is the relative lack of sedating ef-
fect. However, it is considered one of the medicines most
commonly responsible for dosing errors in childhood by
the Royal College Paediatrics and Child Health [18].
Historically, doses quoted for iv Phenytoin and Pheno-
barbitone range from 15–20 mg/kg. The guidelines already
recommend 20 mg/kg as the dose for iv Phenobarbitone
[7]. The difference between 20 mg/kg and 18 mg/kg,
2 mg/kg is 11.1% of 18 mg/kg. This is relatively small. The
18 mg/kg dose was first published to our knowledge in the
paper by David M. Treiman et al [19]. This report doesdoctor or medical student.
Figure 3 Scatter plot of time taken with and without a calculator to calculate 18 mg/kg and 20 mg/kg.
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feel it implausible that such a small increase in the dose
would have an overall pharmacological effect in this
population, especially as the child’s weight is often esti-
mated rather than measured as it is a medical emergency
and they are convulsing, which makes weighing them im-
practical. We feel that a randomised controlled trial
would be too costly and cumbersome for such a minor
difference in dose, but that routine surveillance (clinical
audit) would be useful to compare 18 mg/kg and 20 mg/
kg as used in different units. At least major adverse
events would be recorded this way.
We contacted Pfizer pharmaceutical company which
now owns Parke-Davis who initially marketed EPANUTIN®
(phenytoin sodium). According to Pfizer the dose of
18 mg/kg quoted was derived from numerous clinicalFigure 4 Time taken to perform the calculation by seniority.pharmacology studies (dose response studies) along with
safety data from their phase 3 clinical programme.
Intravenous Phenytoin infusion can sometimes cause
adverse cardiovascular effects, including bradycardia or
hypotension [20]; hence in children the infusion rate
should not exceed 1 mg/kg/min and should be adminis-
tered with cardiac monitoring.
It is well known that many hospitals’ local guidelines ad-
vocate 20 mg/kg for iv Phenytoin for the management of
children with prolonged seizures. To the best of our
knowledge there have been no reports suggesting an in-
creased risk of adverse effects with the 20 mg/kg dose
compared with 18 mg/kg dose.
For this educational exercise, only calculation errors
greater than 10% different from the correct dose were
counted as significant errors.
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the speed much quicker for calculating 20 mg/kg dose
when compared with the current recommended dose
18 mg/kg dose, without a calculator [7].
The exercise demonstrated that doctors and medical
students will make errors in simple dose calculations in at
best 0.3-1% of calculations even with a calculator. These
errors may be higher in the real life scenarios as managing
status epilepticus is a medical emergency which can be
stressful, making us more prone for errors. This under-
lines the importance of checking all dose calculations. The
longer time taken to calculate 18 mg/kg than 20 mg/kg re-
flects the increased difficulty of the calculation without an
electronic calculator, and while many doctors and nurses
in emergency health care settings have their personal cal-
culators to hand, when a calculator is not immediately to
hand, trying to find one will add to delays and stress. Fur-
thermore, it is good practice when using a calculator to
mentally check the result to see if it is “ball-park” correct,
in case of a typing error, such as a misplaced decimal point
that could lead to a ten-fold dosing error.
We propose that new status epilepticus guidelines
should make an attempt to minimise iv Phenytoin dose
calculation difficulties and minimise the risk of errors
and therefore recommend 20 mg/kg.
In the latest edition of ‘Advanced Paediatric Life Support’,
the status epilepticus algorithm now advises 20 mg/kg iv
Phenytoin, replacing the previously recommended dose of
18 mg/kg [21].
Conclusions
Medication errors are common and children are at par-
ticular risk. We recommend iv Phenytoin at 20 mg/kg
rather than 18 mg/kg. This will make the calculation easier
and reduce the risk of significant errors. Ease of dose cal-
culation without an electronic calculator should be taken
into account when making recommendations for drug
doses in children, especially those to be used in emergency
situations. All dose calculations should be checked.
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What is known about this topic
1. Some guidelines recommend Phenytoin iv 18 mg/kg, some 20 mg/kg for
prolonged convulsive epileptic seizures not responding to at least 2 doses of
benzodiazepine.2. A seminal paper by Treiman et al., published in 1998 used iv Phenytoin 18 mg/kg.
What this study adds
1. Students and prescribers were significantly less likely to make significant
dose errors when calculating 20 mg/kg doses than 18 mg/kg doses, without
an electronic calculator.
2. Medical students, trainees and consultants all made errors when
calculating doses using 18 mg/kg without a calculator, in approximately 9%
of their calculations.
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